FTAI vs NVT

FTAI presents a stark contrast between aggressive growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 2/9. While the company exhibits impressive revenue and earnings growth (~30%) and maintains a strong analyst consensus, it is severely overvalued relative to its Graham Number ($18.36) and Intrinsic Value ($135.70). The extreme Debt/Equity ratio of 10.46 suggests a highly leveraged capital structure that offsets the high ROE. Consequently, the stock is a high-risk growth play where current pricing relies heavily on future earnings expectations rather than current balance sheet strength.

NVT exhibits exceptional operational health with a perfect Piotroski F-Score of 9/9 and robust revenue growth of 41.8%. However, the stock is severely overvalued relative to deterministic baselines, trading at $142.90 against a Graham Number of $36.73 and an Intrinsic Value of $76.70. While fundamental growth is explosive, the combination of a bearish technical trend (10/100), bearish insider selling by the CEO, and a current price nearly touching the analyst target ceiling ($144.54) suggests limited immediate upside.